Zhao R, Lu W, Fang X, Guo L, Yang Z, Ye N, Zhao J, Liu Z, Jia J, Zheng L, Zhao B, Zhang A, Zhen X. (6aR)-11-amino-N-propyl-noraporphine, a new dopamine D2 and serotonin 5-HT1A dual agonist, elicits potent antiparkinsonian action and attenuates levodopa-induced dyskinesia in a 6-OHDA-lesioned rat model of Parkinson’s disease. Pharmacol Biochem Behav. 2014;124:204–10.

Article  CAS  Google Scholar 

Khatri DK, Choudhary M, Sood A, Singh SB. Anxiety: an ignored aspect of Parkinson’s disease lacking attention. Biomed Pharmacother. 2020;131:110776.

Article  CAS  Google Scholar 

Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders: a systematic review and meta-analysis. Life Sci. 2021;281:119767.

Article  CAS  Google Scholar 

Kuresan H, Samiappan D, Reddy P-M, Mahesh R-S, Sriharsha K. Parkinson’s disease analysis using speech signal processing – a research inclination for graduates. Mater Today: Proc. 2021.

Niemann N, Billnitzer A, Jankovic J. Parkinson’s disease and skin. Parkinsonism Relat D. 2021;82:61–76.

Article  Google Scholar 

Kusuda Y, Takemura A, Nakano M, Ishihara A. Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantia nigra of mice with MPTP-induced Parkinson’s disease. Neurosci Res. 2018;132:58–62.

Article  CAS  Google Scholar 

Anamnart C, Kitjarak R. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson’s disease patients: a randomized controlled study. J Clin Neurosci. 2021;88:226–31.

Article  CAS  Google Scholar 

Sasahara K, Nitanai T, Habara T, Morioka T, Nakajima E. Dosage form design for improvement of bioavailability of levodopa V: absorption and metabolism of levodopa in intestinal segments of dogs. J Pharm Sci. 1981;70(10):1157–60.

Article  CAS  Google Scholar 

Park SW, Kim TE, Jung YK. Glutathione-decorated fluorescent carbon quantum dots for sensitive and selective detection of levodopa. Anal Chim Acta. 2021;1165:338513.

Article  CAS  Google Scholar 

Miraki M, Karimi-Maleh H, Taher MA, Cheraghi S, Gupta VK. Voltammetric amplified platform based on ionic liquid/NiO nanocomposite for determination of benserazide and levodopa[J]. J Mol Liq. 2019;278:672–6.

Article  CAS  Google Scholar 

Müller T. Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: efficacy, safety and patient preference. Patient Prefer Adherence. 2009;3:51–9.

Article  Google Scholar 

César I-C, Byrro R-M-D, Santana e Silva-Cardoso F-F, Mundim I-M, Souza Teixeira L, Gomes S-A, Bonfim R-R, Pianetti G-A. Development and validation of a high-performance liquid chromatography-electrospray ionization-MS/MS method for the simultaneous quantitation of levodopa and carbidopa in human plasma. J Mass Spectrom. 2011;46:943–8.

Article  Google Scholar 

César Ida C, Byrro RM, Cardoso FF, Mundim IM, Teixeira Lde S, da Silva EP, Gomes SA, Bonfim RR, Pianetti GA. Simultaneous quantitation of levodopa and 3-O-methyldopa in human plasma by HPLC-ESI-MS/MS: application for a pharmacokinetic study with a levodopa/benserazide formulation. J Pharm Biomed Anal. 2011;56(5):1094–100.

Article  Google Scholar 

Freitas ME, Ruiz-Lopez M, Fox SH. Novel levodopa formulations for Parkinson’s disease. CNS Drugs. 2016;30(11):1079–95. https://doi.org/10.1007/s40263-016-0386-8. PMID: 27743318.

Article  CAS  Google Scholar 

Nunes T, Machado R, Rocha JF, Fernandes-Lopes C, Costa R, Torrão L, Loureiro AI, Falcão A, Vaz-da-Silva M, Wright L, Almeida L, Soares-da-Silva P. Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects. Clin Ther. 2009;31(10):2258–71.

Article  CAS  Google Scholar 

Erni W, Held K. The hydrodynamically balanced system: a novel principle of controlled drug release. Eur Neurol. 1987;27(Suppl 1):21–7. https://doi.org/10.1159/000116171. PMID: 3322836.

Article  CAS  Google Scholar 

Fu J, Yin H, Yu X, Xie C, Jiang H, Jin Y, Sheng F. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. Int J Pharm. 2018;549(1–2):370–9.

Article  CAS  Google Scholar 

Zhao Q, Gao B, Ma L, Lian J, Deng L, Chen J. Innovative intragastric ascaridole floating tablets: development, optimization, and in vitro-in vivo evaluation. Int J Pharm. 2015;496(2):432–9.

Article  CAS  Google Scholar 

Treesinchai S, Puttipipatkhachorn S, Pitaksuteepong T, Sungthongjeen S. Development of curcumin floating tablets based on low density foam powder. Asian J Pharm Sci. 2016;11(1):130–1.

Article  Google Scholar 

Awasthi R, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Deliv. 2016;23(2):378–94.

Article  CAS  Google Scholar 

Amit P, Harinath D, Kamla P. Decades of research in drug targeting using gastroretentive drug delivery systems for antihypertensive therapy. Braz j pharm. 2017;53(3):e00173.

Google Scholar 

Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv. 2011;18(2):97–110.

Article  CAS  Google Scholar 

Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y, Yang L, He W, Han X, Yin L. Design and optimization of gastro-floating sustained-release tablet of pregabalin: in vitro and in vivo evaluation. Int J Pharm. 2018;545(1–2):37–44.

Article  CAS  Google Scholar 

Anothra P, Pradhan D, Naik P. K, Ghosh G, Rath G. Development and characterization of 5-fluorouracil nanofibrous film for the treatment of stomach cancer. J Drug Deliv Sci Technol. 2021;61:102219.

Article  CAS  Google Scholar 

Rahamathulla M, Alsahhrani SM, Al Saqr A, Alshetaili A, Shakeel F. Effervescent floating matrix tablets of a novel anti-cancer drug neratinib for breast cancer treatment. J Drug Deliv Sci Technol. 2021;66:102788.

Article  CAS  Google Scholar 

HW Huh, Na YG, Kang H, Kim M, Han M, Pham TMA, Lee H, Baek JS, Lee HK, Cho CW. Novel self-floating tablet for enhanced oral bioavailability of metformin based on cellulose. Int J Pharm. 2021;592:120113.

Article  Google Scholar 

Lalge R, Thipsay P, Shankar VK, Maurya A, Pimparade M, Bandari S, Zhang F, Murthy SN, Repka MA. Preparation and evaluation of cefuroxime axetil gastro-retentive floating drug delivery system via hot melt extrusion technology. Int J Pharm. 2019;566:520–31.

Article  CAS  Google Scholar 

Gaikwad SS, Avari JG. Improved bioavailability of azelnidipine gastro retentive tablets-optimization and in-vivo assessment. Mater Sci Eng C Mater Biol Appl. 2019;103:109800.

Article  CAS  Google Scholar 

Kumar A, Chanda S, Agarwal S et al. Formulation and evaluation of gastro-retentive tinidazole loaded floating microsphere for sustained release. Mater Today: Proc.

Müller T. Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: efficacy, safety and patient preference. Patient Prefer Adher. 2009;3:51–9.

Article  Google Scholar